Study population
DNN accelerated knee, pain
RECRUITMENT, DYSFUNCTION
This prospective study from a single tertiary center was approved by the Institutional Review Board of Yonsei University’s Health System (IRB No: 1-2022-0017). Written informed consent was obtained from all enrolled participants. Our study complied with both the Declaration of Helsinki and the Health Insurance Portability and Accountability Act.Study recruitment commenced from August 2022 to October 2022. Inclusion criteria were: (1) clinically indicated patient for knee MRI; (2) an agreement to participate in DNN accelerated knee MRI; (3) age of 30 years or older; (4) the ability to position the knee in MRI; and (5) symptomatic knees associated with pain and dysfunction knee. Exclusion criteria consisted of (1) orthopedic implants in the knee region and (2) other general contraindications for MRI. The flow chart for prospective study enrollment is shown in Fig. Flow chart for prospective study enrollment to evaluate conventional FSE (FSE-conventional) and accelerated MR sequences with DNN reconstruction (FSE-DNN).